Global HIV Vaccines Market Size, Status and Forecast 2021-2027
SKU ID : QYR-17253676 | Publishing Date : 25-Jan-2021 | No. of pages : 99
Detailed TOC of Global HIV Vaccines Market Size, Status and Forecast 2021-2027
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HIV Vaccines Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Phase I
1.2.3 Phase II
1.2.4 Phase III
1.3 Market by Application
1.3.1 Global HIV Vaccines Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Research Institute
1.3.3 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global HIV Vaccines Market Perspective (2016-2027)
2.2 HIV Vaccines Growth Trends by Regions
2.2.1 HIV Vaccines Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 HIV Vaccines Historic Market Share by Regions (2016-2021)
2.2.3 HIV Vaccines Forecasted Market Size by Regions (2022-2027)
2.3 HIV Vaccines Industry Dynamic
2.3.1 HIV Vaccines Market Trends
2.3.2 HIV Vaccines Market Drivers
2.3.3 HIV Vaccines Market Challenges
2.3.4 HIV Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top HIV Vaccines Players by Revenue
3.1.1 Global Top HIV Vaccines Players by Revenue (2016-2021)
3.1.2 Global HIV Vaccines Revenue Market Share by Players (2016-2021)
3.2 Global HIV Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by HIV Vaccines Revenue
3.4 Global HIV Vaccines Market Concentration Ratio
3.4.1 Global HIV Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HIV Vaccines Revenue in 2020
3.5 HIV Vaccines Key Players Head office and Area Served
3.6 Key Players HIV Vaccines Product Solution and Service
3.7 Date of Enter into HIV Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 HIV Vaccines Breakdown Data by Type
4.1 Global HIV Vaccines Historic Market Size by Type (2016-2021)
4.2 Global HIV Vaccines Forecasted Market Size by Type (2022-2027)
5 HIV Vaccines Breakdown Data by Application
5.1 Global HIV Vaccines Historic Market Size by Application (2016-2021)
5.2 Global HIV Vaccines Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America HIV Vaccines Market Size (2016-2027)
6.2 North America HIV Vaccines Market Size by Type
6.2.1 North America HIV Vaccines Market Size by Type (2016-2021)
6.2.2 North America HIV Vaccines Market Size by Type (2022-2027)
6.2.3 North America HIV Vaccines Market Size by Type (2016-2027)
6.3 North America HIV Vaccines Market Size by Application
6.3.1 North America HIV Vaccines Market Size by Application (2016-2021)
6.3.2 North America HIV Vaccines Market Size by Application (2022-2027)
6.3.3 North America HIV Vaccines Market Size by Application (2016-2027)
6.4 North America HIV Vaccines Market Size by Country
6.4.1 North America HIV Vaccines Market Size by Country (2016-2021)
6.4.2 North America HIV Vaccines Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe HIV Vaccines Market Size (2016-2027)
7.2 Europe HIV Vaccines Market Size by Type
7.2.1 Europe HIV Vaccines Market Size by Type (2016-2021)
7.2.2 Europe HIV Vaccines Market Size by Type (2022-2027)
7.2.3 Europe HIV Vaccines Market Size by Type (2016-2027)
7.3 Europe HIV Vaccines Market Size by Application
7.3.1 Europe HIV Vaccines Market Size by Application (2016-2021)
7.3.2 Europe HIV Vaccines Market Size by Application (2022-2027)
7.3.3 Europe HIV Vaccines Market Size by Application (2016-2027)
7.4 Europe HIV Vaccines Market Size by Country
7.4.1 Europe HIV Vaccines Market Size by Country (2016-2021)
7.4.2 Europe HIV Vaccines Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific HIV Vaccines Market Size (2016-2027)
8.2 Asia-Pacific HIV Vaccines Market Size by Type
8.2.1 Asia-Pacific HIV Vaccines Market Size by Type (2016-2021)
8.2.2 Asia-Pacific HIV Vaccines Market Size by Type (2022-2027)
8.2.3 Asia-Pacific HIV Vaccines Market Size by Type (2016-2027)
8.3 Asia-Pacific HIV Vaccines Market Size by Application
8.3.1 Asia-Pacific HIV Vaccines Market Size by Application (2016-2021)
8.3.2 Asia-Pacific HIV Vaccines Market Size by Application (2022-2027)
8.3.3 Asia-Pacific HIV Vaccines Market Size by Application (2016-2027)
8.4 Asia-Pacific HIV Vaccines Market Size by Region
8.4.1 Asia-Pacific HIV Vaccines Market Size by Region (2016-2021)
8.4.2 Asia-Pacific HIV Vaccines Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America HIV Vaccines Market Size (2016-2027)
9.2 Latin America HIV Vaccines Market Size by Type
9.2.1 Latin America HIV Vaccines Market Size by Type (2016-2021)
9.2.2 Latin America HIV Vaccines Market Size by Type (2022-2027)
9.2.3 Latin America HIV Vaccines Market Size by Type (2016-2027)
9.3 Latin America HIV Vaccines Market Size by Application
9.3.1 Latin America HIV Vaccines Market Size by Application (2016-2021)
9.3.2 Latin America HIV Vaccines Market Size by Application (2022-2027)
9.3.3 Latin America HIV Vaccines Market Size by Application (2016-2027)
9.4 Latin America HIV Vaccines Market Size by Country
9.4.1 Latin America HIV Vaccines Market Size by Country (2016-2021)
9.4.2 Latin America HIV Vaccines Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa HIV Vaccines Market Size (2016-2027)
10.2 Middle East & Africa HIV Vaccines Market Size by Type
10.2.1 Middle East & Africa HIV Vaccines Market Size by Type (2016-2021)
10.2.2 Middle East & Africa HIV Vaccines Market Size by Type (2022-2027)
10.2.3 Middle East & Africa HIV Vaccines Market Size by Type (2016-2027)
10.3 Middle East & Africa HIV Vaccines Market Size by Application
10.3.1 Middle East & Africa HIV Vaccines Market Size by Application (2016-2021)
10.3.2 Middle East & Africa HIV Vaccines Market Size by Application (2022-2027)
10.3.3 Middle East & Africa HIV Vaccines Market Size by Application (2016-2027)
10.4 Middle East & Africa HIV Vaccines Market Size by Country
10.4.1 Middle East & Africa HIV Vaccines Market Size by Country (2016-2021)
10.4.2 Middle East & Africa HIV Vaccines Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Argos Therapeutics
11.1.1 Argos Therapeutics Company Details
11.1.2 Argos Therapeutics Business Overview
11.1.3 Argos Therapeutics HIV Vaccines Introduction
11.1.4 Argos Therapeutics Revenue in HIV Vaccines Business (2016-2021)
11.1.5 Argos Therapeutics Recent Development
11.2 Bionor Pharma
11.2.1 Bionor Pharma Company Details
11.2.2 Bionor Pharma Business Overview
11.2.3 Bionor Pharma HIV Vaccines Introduction
11.2.4 Bionor Pharma Revenue in HIV Vaccines Business (2016-2021)
11.2.5 Bionor Pharma Recent Development
11.3 Janssen Global Services
11.3.1 Janssen Global Services Company Details
11.3.2 Janssen Global Services Business Overview
11.3.3 Janssen Global Services HIV Vaccines Introduction
11.3.4 Janssen Global Services Revenue in HIV Vaccines Business (2016-2021)
11.3.5 Janssen Global Services Recent Development
11.4 Genecure
11.4.1 Genecure Company Details
11.4.2 Genecure Business Overview
11.4.3 Genecure HIV Vaccines Introduction
11.4.4 Genecure Revenue in HIV Vaccines Business (2016-2021)
11.4.5 Genecure Recent Development
11.5 Geovax,
11.5.1 Geovax, Company Details
11.5.2 Geovax, Business Overview
11.5.3 Geovax, HIV Vaccines Introduction
11.5.4 Geovax, Revenue in HIV Vaccines Business (2016-2021)
11.5.5 Geovax, Recent Development
11.6 Paxvax Corporation
11.6.1 Paxvax Corporation Company Details
11.6.2 Paxvax Corporation Business Overview
11.6.3 Paxvax Corporation HIV Vaccines Introduction
11.6.4 Paxvax Corporation Revenue in HIV Vaccines Business (2016-2021)
11.6.5 Paxvax Corporation Recent Development
11.7 Inovio Pharmaceuticals
11.7.1 Inovio Pharmaceuticals Company Details
11.7.2 Inovio Pharmaceuticals Business Overview
11.7.3 Inovio Pharmaceuticals HIV Vaccines Introduction
11.7.4 Inovio Pharmaceuticals Revenue in HIV Vaccines Business (2016-2021)
11.7.5 Inovio Pharmaceuticals Recent Development
11.8 Glaxosmithkline
11.8.1 Glaxosmithkline Company Details
11.8.2 Glaxosmithkline Business Overview
11.8.3 Glaxosmithkline HIV Vaccines Introduction
11.8.4 Glaxosmithkline Revenue in HIV Vaccines Business (2016-2021)
11.8.5 Glaxosmithkline Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi HIV Vaccines Introduction
11.9.4 Sanofi Revenue in HIV Vaccines Business (2016-2021)
11.9.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global HIV Vaccines Market Size, Status and Forecast 2021-2027
List of TablesTable 1. Global HIV Vaccines Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Phase I
Table 3. Key Players of Phase II
Table 4. Key Players of Phase III
Table 5. Global HIV Vaccines Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global HIV Vaccines Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global HIV Vaccines Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global HIV Vaccines Market Share by Regions (2016-2021)
Table 9. Global HIV Vaccines Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global HIV Vaccines Market Share by Regions (2022-2027)
Table 11. HIV Vaccines Market Trends
Table 12. HIV Vaccines Market Drivers
Table 13. HIV Vaccines Market Challenges
Table 14. HIV Vaccines Market Restraints
Table 15. Global HIV Vaccines Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global HIV Vaccines Market Share by Players (2016-2021)
Table 17. Global Top HIV Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HIV Vaccines as of 2020)
Table 18. Ranking of Global Top HIV Vaccines Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by HIV Vaccines Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players HIV Vaccines Product Solution and Service
Table 22. Date of Enter into HIV Vaccines Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global HIV Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 25. Global HIV Vaccines Revenue Market Share by Type (2016-2021)
Table 26. Global HIV Vaccines Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global HIV Vaccines Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global HIV Vaccines Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global HIV Vaccines Revenue Market Share by Application (2016-2021)
Table 30. Global HIV Vaccines Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global HIV Vaccines Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America HIV Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 33. North America HIV Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America HIV Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 35. North America HIV Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America HIV Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America HIV Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe HIV Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe HIV Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe HIV Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe HIV Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe HIV Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe HIV Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific HIV Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific HIV Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific HIV Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific HIV Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific HIV Vaccines Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific HIV Vaccines Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America HIV Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America HIV Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America HIV Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America HIV Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America HIV Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America HIV Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa HIV Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa HIV Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa HIV Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa HIV Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa HIV Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa HIV Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 62. Argos Therapeutics Company Details
Table 63. Argos Therapeutics Business Overview
Table 64. Argos Therapeutics HIV Vaccines Product
Table 65. Argos Therapeutics Revenue in HIV Vaccines Business (2016-2021) & (US$ Million)
Table 66. Argos Therapeutics Recent Development
Table 67. Bionor Pharma Company Details
Table 68. Bionor Pharma Business Overview
Table 69. Bionor Pharma HIV Vaccines Product
Table 70. Bionor Pharma Revenue in HIV Vaccines Business (2016-2021) & (US$ Million)
Table 71. Bionor Pharma Recent Development
Table 72. Janssen Global Services Company Details
Table 73. Janssen Global Services Business Overview
Table 74. Janssen Global Services HIV Vaccines Product
Table 75. Janssen Global Services Revenue in HIV Vaccines Business (2016-2021) & (US$ Million)
Table 76. Janssen Global Services Recent Development
Table 77. Genecure Company Details
Table 78. Genecure Business Overview
Table 79. Genecure HIV Vaccines Product
Table 80. Genecure Revenue in HIV Vaccines Business (2016-2021) & (US$ Million)
Table 81. Genecure Recent Development
Table 82. Geovax, Company Details
Table 83. Geovax, Business Overview
Table 84. Geovax, HIV Vaccines Product
Table 85. Geovax, Revenue in HIV Vaccines Business (2016-2021) & (US$ Million)
Table 86. Geovax, Recent Development
Table 87. Paxvax Corporation Company Details
Table 88. Paxvax Corporation Business Overview
Table 89. Paxvax Corporation HIV Vaccines Product
Table 90. Paxvax Corporation Revenue in HIV Vaccines Business (2016-2021) & (US$ Million)
Table 91. Paxvax Corporation Recent Development
Table 92. Inovio Pharmaceuticals Company Details
Table 93. Inovio Pharmaceuticals Business Overview
Table 94. Inovio Pharmaceuticals HIV Vaccines Product
Table 95. Inovio Pharmaceuticals Revenue in HIV Vaccines Business (2016-2021) & (US$ Million)
Table 96. Inovio Pharmaceuticals Recent Development
Table 97. Glaxosmithkline Company Details
Table 98. Glaxosmithkline Business Overview
Table 99. Glaxosmithkline Revenue in HIV Vaccines Business (2016-2021) & (US$ Million)
Table 100. Glaxosmithkline Recent Development
Table 101. Sanofi Company Details
Table 102. Sanofi Business Overview
Table 103. Sanofi HIV Vaccines Product
Table 104. Sanofi Revenue in HIV Vaccines Business (2016-2021) & (US$ Million)
Table 105. Sanofi Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global HIV Vaccines Market Share by Type: 2020 VS 2027
Figure 2. Phase I Features
Figure 3. Phase II Features
Figure 4. Phase III Features
Figure 5. Global HIV Vaccines Market Share by Application: 2020 VS 2027
Figure 6. Research Institute Case Studies
Figure 7. Other Case Studies
Figure 8. HIV Vaccines Report Years Considered
Figure 9. Global HIV Vaccines Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global HIV Vaccines Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global HIV Vaccines Market Share by Regions: 2020 VS 2027
Figure 12. Global HIV Vaccines Market Share by Regions (2022-2027)
Figure 13. Global HIV Vaccines Market Share by Players in 2020
Figure 14. Global Top HIV Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HIV Vaccines as of 2020
Figure 15. The Top 10 and 5 Players Market Share by HIV Vaccines Revenue in 2020
Figure 16. Global HIV Vaccines Revenue Market Share by Type (2016-2021)
Figure 17. Global HIV Vaccines Revenue Market Share by Type (2022-2027)
Figure 18. North America HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America HIV Vaccines Market Share by Type (2016-2027)
Figure 20. North America HIV Vaccines Market Share by Application (2016-2027)
Figure 21. North America HIV Vaccines Market Share by Country (2016-2027)
Figure 22. United States HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe HIV Vaccines Market Share by Type (2016-2027)
Figure 26. Europe HIV Vaccines Market Share by Application (2016-2027)
Figure 27. Europe HIV Vaccines Market Share by Country (2016-2027)
Figure 28. Germany HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific HIV Vaccines Market Share by Type (2016-2027)
Figure 36. Asia-Pacific HIV Vaccines Market Share by Application (2016-2027)
Figure 37. Asia-Pacific HIV Vaccines Market Share by Region (2016-2027)
Figure 38. China HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America HIV Vaccines Market Share by Type (2016-2027)
Figure 46. Latin America HIV Vaccines Market Share by Application (2016-2027)
Figure 47. Latin America HIV Vaccines Market Share by Country (2016-2027)
Figure 48. Mexico HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa HIV Vaccines Market Share by Type (2016-2027)
Figure 52. Middle East & Africa HIV Vaccines Market Share by Application (2016-2027)
Figure 53. Middle East & Africa HIV Vaccines Market Share by Country (2016-2027)
Figure 54. Turkey HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Argos Therapeutics Revenue Growth Rate in HIV Vaccines Business (2016-2021)
Figure 58. Bionor Pharma Revenue Growth Rate in HIV Vaccines Business (2016-2021)
Figure 59. Janssen Global Services Revenue Growth Rate in HIV Vaccines Business (2016-2021)
Figure 60. Genecure Revenue Growth Rate in HIV Vaccines Business (2016-2021)
Figure 61. Geovax, Revenue Growth Rate in HIV Vaccines Business (2016-2021)
Figure 62. Paxvax Corporation Revenue Growth Rate in HIV Vaccines Business (2016-2021)
Figure 63. Inovio Pharmaceuticals Revenue Growth Rate in HIV Vaccines Business (2016-2021)
Figure 64. Glaxosmithkline Revenue Growth Rate in HIV Vaccines Business (2016-2021)
Figure 65. Sanofi Revenue Growth Rate in HIV Vaccines Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Keyplayers in Global HIV Vaccines Market Size, Status and Forecast 2021-2027
Argos TherapeuticsBionor Pharma
Janssen Global Services
Genecure
Geovax,
Paxvax Corporation
Inovio Pharmaceuticals
Glaxosmithkline
Sanofi